Profil
Diane Burgess is the founder and advisor at Diant Pharma, Inc. which is founded in 2019.
She is currently the owner of HBF Marble & Granite LLC.
Postes actifs de Diane Burgess
| Sociétés | Poste | Début |
|---|---|---|
HBF Marble & Granite LLC
 HBF Marble & Granite LLC Construction MaterialsNon-Energy Minerals HBF Marble & Granite LLC manufactures cut stone and stone products. The company was founded in 1997 and is headquartered in Denver, CO | Corporate Officer/Principal | 30/11/2010 |
Diant Pharma, Inc.
 Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Fondateur | 01/01/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
HBF Marble & Granite LLC
HBF Marble & Granite LLC Construction MaterialsNon-Energy Minerals HBF Marble & Granite LLC manufactures cut stone and stone products. The company was founded in 1997 and is headquartered in Denver, CO | Non-Energy Minerals |
Diant Pharma, Inc.
Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Health Technology |
